Back to search

University of Ioannina

Μοριακός καρυότυπος στην προγεννητική διάγνωση

Abstract

dc:description

Karyotyping has been the golden standard method for prenatal diagnosis fordecades, for the diagnosis of numerical and large structural abnormalities (<3-10Mb).With the introduction of array Comparative Genomic Hybridization (CGH) analysis inpostnatal analysis and its use as a first-tier test in cases of Intellectual disabilities, ithas been postulated that this method might also become the first-tier test in prenataldiagnosis as well. Αrray CGH is a technology that has demonstrated that it is a highthroughput, comprehensive and fast and has proven its ability to detect copy numberchanges that can go undetected by light microscopy.The aim of this study was the application of high-resolution microarrays in prenataldiagnosis for the detection of cryptic microduplications and microdeletions in fetuseswith ultrasound abnormalities and normal karyotype, and also to further investigatethe abnormalities in fetuses with balanced or unbalanced rearrangements with orwithout ultrasound findings. This research aimed to provide new scientific knowledgeand benefits in fetal medicine and genetics, and to prove that the application ofhigher diagnostic resolution in prenatal diagnosis is possible.Array CGH was carried out to detect submicroscopic chromosomal imbalances,using commercially available Bacterial Artificial Chromosome (BAC) andoligonucleotide microarrays (Cytochip BlueGnome), as well as the Sanger Tiling PathBAC arrays. All Copy Number Changes (CNCs) revealed in array analysis wereconfirmed by a second method. A total of 202, out of which 129 were prenatal, and64 parental samples were analyzed. Prenatal samples were tested either because: 1)they had normal karyotype and ultrasound abnormalities, 2) apparently balancedrearrangement and ultrasound abnormalities, 3) an apparently balanced structural aberration without abnormal ultrasound findings, 4) an abnormal karyotype withabnormal ultrasound findings, 5) an abnormal karyotype/ MLPA/QF-PCR withoutabnormal ultrasound findings which required further investigation, 6) even though thekaryotype was eventually normal and there were no ultrasound findings array CGHwas carried out because of maternal anxiety due to an abnormal previous pregnancyor to rule out a possible abnormality which was revealed during chromosomal/ MLPA/Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) analyses.Fifty prenatal samples were analyzed with 1Mb BAC arrays, 34 with 105K and 11with 180K oligonucleotide arrays and 34 samples were analyzed with Tiling path BACarray. Seventeen abnormal cases (17/95, 17.9%) were determined by array CGHanalysis. Seven of the abnormal cases were from pregnancies which had ultrasoundabnormalities and a normal karyotype, whereas 9 of the abnormalities wereinvestigations of abnormalities detected by other methods (G Banding, MLPA, QFPCR) (9/17, 53%). By excluding the nine abnormalities previously detected with othermethods the detection rate of this method is 8.1% (7 out of 86 samples).The current prenatal cohort included 34 cases that had a normal karyotype and wereterminated due to major ultrasound abnormalities. Array CGH analysis of theses 34fetuses revealed 627 Copy Number Changes (CNC). After comparison to knownaberrations listed in publically available databases, (DECIPHER (DatabasE ofChromosomal Imbalance and Phenotype in Humans using Ensembl Resources,Database of Genomic Variants DGV) it was determined that these CNCs were foundwithin normal copy number variant regions and were excluded from any furtherinvestigation. These CNCs were considered of no clinical significance as they couldalso be found in normal controls and thus were most probably not associated with theclinical findings. Finally among the 202 samples there were 73 cases of Products of Conception/intrauterine death /Stillbirth (POC/SB) samples which were initially received forchromosomal analysis. Due to failure of these samples to grow in vitro , additionaltissue kept in storage was used for DNA extraction, so that they could be used in(QF- PCR) and array CGH analyses.Out of the 73 POC/SB samples, 16 cases were completed by QF PCR analysis only,as the causative abnormality was detected and there was no need to proceed withany further investigation and 57 cases were further investigated using array CGHanalysis. Out of the 16 abnormalities detected with QF PCR analysis 13 were firsttrimester and 3 were second trimester miscarriages; 4 triploidies, 8 autosomaltrisomies and 4 sex chromosome abnormalities. Out of the 57 cases investigatedwith array CGH, 49 were analyzed using BAC arrays and 8 were analyzed usingOligo arrays. A total of 9 aneuploidies were detected by BAC arrays analysis, ofwhich 7 were autosomal and 2 were sex chromosome aneuploidies. Eight of thoseaneuploidies were first trimester and one was second trimester miscarriage. Inaddition 1 benign familial CNC was detected by oligo array analysis.Array CGH analysis has been proven to be a valuable tool for the determination ofcopy number changes in children with congenital abnormalities and it has replacedkaryotyping in some laboratories. It has proven its value in Products of Conception/Intrauterine death /Stillbirth as shown in this study by having the advantage tocircumvent technical problems associated with tissue culturing thus leading to thefailure of providing results by classical cytogenetics.In prenatal diagnosis chromosomal analysis is still the primary choice of testing; ithas to overcome some of its limitations, such as the detection of CNCs of unclearsignificance or coincidental findings, before it can fully replace chromosomal analysisin prenatal diagnosis. Αs it was shown, by our results and those of others, the detection rate in clinically significant copy number changes is increased by 8% withthe application of array CGH in cases were the karyotype is normal and there aresonographic malformations in the fetus it can be used more extensively in prenataldiagnosis as well. Furthermore in 9 cases it has provided additional information,valuable for the clinical interpretation of the findings detected by othermethodologies.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Evangelidou-Mavrogeni, Paola
  • Ευαγγελίδου-Μαυρογένη, Πάολα

Subjects

dc:subject × 17

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36991

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Evangelidou-Mavrogeni, Paola; Ευαγγελίδου-Μαυρογένη, Πάολα. Μοριακός καρυότυπος στην προγεννητική διάγνωση. University of Ioannina, 2012. http://hdl.handle.net/10442/hedi/36991